TODDE, SERGIO CAMILLO
TODDE, SERGIO CAMILLO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method
2024 Iannone, M; Valtorta, S; Stucchi, S; Altomonte, S; Turolla, E; Vino, E; Rainone, P; Zecca, V; Lo Dico, A; Maspero, M; Figini, M; Bellone, M; Ciceri, S; Colombo, D; Chinello, C; Pagani, L; Moresco, R; Todde, S; Ferraboschi, P
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
2024 Toyohara, J; Vugts, D; Kiss, O; Todde, S; Li, X; Liu, Z; Yang, Z; Gillings, N; Cazzola, E; Szymanski, W; Meulen, N; Reilly, R; Taddei, C; Schirrmacher, R; Li, Z; Lagebo, Y; Bentaleb, N; Souza Albernaz, M; Lapi, S; Ramogida, C; Mukherjee, A; Ajenjo, J; Deuther-Conrad, W; Bourdeau, C
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework
2024 Korde, A; Patt, M; Selivanova, S; Scott, A; Hesselmann, R; Kiss, O; Ramamoorthy, N; Todde, S; Rubow, S; Gwaza, L; Lyashchenko, S; Andersson, J; Hockley, B; Kaslival, R; Decristoforo, C
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models
2023 Rainone, P; Valtorta, S; Villa, C; Todde, S; Cadamuro, M; Bertoli, G; Conconi, D; Lavitrano, M; Moresco, R
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'
2023 Boschi, S; Todde, S
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification
2022 De Ponti, E; Crivellaro, C; Morzenti, S; Monaco, L; Todde, S; Landoni, C; Elisei, F; Musarra, M; Guerra, L
EANM guideline on quality risk management for radiopharmaceuticals
2022 Gillings, N; Hjelstuen, O; Behe, M; Decristoforo, C; Elsinga, P; Ferrari, V; Kiss, O; Kolenc, P; Koziorowski, J; Laverman, P; Mindt, T; Ocak, M; Patt, M; Todde, S; Walte, A
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy
2022 Granata, S; Valtorta, S; Zerbetto, F; Todde, S; Iannone, M; Coliva, T; Spinelli, A; Bertoli, G; de Pretis, S; Diprima, S; Villa, S; DI MUZIO, N; Moresco, R
PET radiopharmacy and automation
2022 Boschi, S; Todde, S
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
2022 Korde, A; Mikolajczak, R; Kolenc, P; Bouziotis, P; Westin, H; Lauritzen, M; Koole, M; Herth, M; Bardiès, M; Martins, A; Paulo, A; Lyashchenko, S; Todde, S; Nag, S; Lamprou, E; Abrunhosa, A; Giammarile, F; Decristoforo, C
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach
2022 Iannone, M; Stucchi, S; Turolla, E; Beretta, C; Ciceri, S; Chinello, C; Pagani, L; Todde, S; Ferraboschi, P
From radiotracer to radiopharmaceutical: a philosophical approach
2021 Boschi, S; Todde, S
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
2021 Gillings, N; Hjelstuen, O; Ballinger, J; Behe, M; Decristoforo, C; Elsinga, P; Ferrari, V; Peitl, P; Koziorowski, J; Laverman, P; Mindt, T; Neels, O; Ocak, M; Patt, M; Todde, S
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
2021 Aime, S; Al-Qahtani, M; Behe, M; Bormans, G; Carlucci, G; Dasilva, J; Decristoforo, C; Duatti, A; Elsinga, P; Kopka, K; Li, X; Liu, Z; Mach, R; Middel, O; Passchier, J; Patt, M; Penuelas, I; Rey, A; Scott, P; Todde, S; Toyohara, J; Vugts, D; Yang, Z
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
2021 Valtorta, S; Lo Dico, A; Raccagni, I; Martelli, C; Pieri, V; Rainone, P; Todde, S; Zinnhardt, B; De Bernardi, E; Coliva, A; Politi, L; Viel, T; Jacobs, A; Galli, R; Ottobrini, L; Vaira, V; Moresco, R
EANM Guideline on the validation of analytical methods for radiopharmaceuticals
2020 Gillings, N; Todde, S; Behe, M; Decristoforo, C; Elsinga, P; Ferrari, V; Hjelstuen, O; Kolenc Peitl, P; Koziorowski, J; Laverman, P; Mindt, T; Ocak, M; Patt, M
Rsdiofarmaci marcati con fluoro-18
2020 Todde, S; Boschi, S
Sperimentazione clinica con radiofarmaci
2020 Moresco, R; Todde, S
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol
2019 Dolci, C; Spadavecchia, C; Crivellaro, C; De Ponti, E; Todde, S; Morzenti, S; Turolla, E; Crespi, A; Guerra, L; Landoni, C
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study
2018 Crivellaro, C; De Ponti, E; Elisei, F; Morzenti, S; Picchio, M; Bettinardi, V; Versari, A; Fioroni, F; Dziuk, M; Tkaczewski, K; Ahond-Vionnet, R; Nodari, G; Todde, S; Landoni, C; Guerra, L